Clinical Trials Logo

Clinical Trial Summary

In the last decade, several authors proposed ultrasound measurement of Bladder wall thickness (BWT) for the screening of the voiding dysfunction and of the detrusor overactivity (DO). The aims of the investigator prospective study were:

- to compare the ultrasonographic measurement of BWT in women with DO vs women with other urodynamic diagnosis in a very large population.

- to verify whether the BWT in women with DO can be different in the clinically or urodinamically different forms of DO.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01003457
Study type Observational
Source Università degli Studi dell'Insubria
Contact
Status Completed
Phase N/A
Start date January 2005
Completion date December 2008

See also
  Status Clinical Trial Phase
Completed NCT04543552 - A Comparative Analysis of Portable Bladder Scanner to Determine Age/ Volume Specific Accuracy in 0-6 Years of Children
Completed NCT04978714 - USI and/or DO in Women With Cystocele Before and After Cystocele Repair
Not yet recruiting NCT04693897 - Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker
Enrolling by invitation NCT00822913 - Botulinum A Toxin in Patients With Parkinson's Disease Phase 4
Terminated NCT00373789 - Refractory Urge Incontinence and Botox Injections Phase 3
Completed NCT01093534 - Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder. Phase 4
Terminated NCT01023269 - Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder N/A
Not yet recruiting NCT05572918 - Developing a Simple Test to Diagnose Overactive Bladder
Completed NCT01850706 - UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation N/A
Completed NCT00478881 - A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function Phase 2
Completed NCT00678795 - A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis Phase 3